BLM and cancer: The mutations of BLM disrupting its ATPase or helicase activity cause BS (27), a rare autosomal recessive genetic disorder characterized by developmental problems, growth retardation, immunodeficiency, sunlight sensitivity, fertility defects, and cancer predisposition associated with genomic and chromosomic instability (28–30).